Skip to main content

. 1989 Sep;44(9):767–768. doi: 10.1136/thx.44.9.767

Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.

K Larsson, P Hjemdahl

PMCID: PMC462072 PMID: 2627224

768

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Harvey J. E., Baldwin C. J., Wood P. J., Alberti K. G., Tattersfield A. E. Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond) 1981 May;60(5):579–585. doi: 10.1042/cs0600579. [DOI] [PubMed] [Google Scholar]
Kaumann A. J., Lemoine H. Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation. Naunyn Schmiedebergs Arch Pharmacol. 1987 Apr;335(4):403–411. doi: 10.1007/BF00165555. [DOI] [PubMed] [Google Scholar]
Larsson S., Svedmyr N. Cumulative dose-response curves for comparison of oral bronchodilating drugs. A study of salbutamol and fenoterol. Ann Allergy. 1977 Nov;39(5):362–366. [PubMed] [Google Scholar]
Pentikäinen P. J., Halinen M. O., Helin M. J. Pharmacokinetics of intravenous mexiletine in patients with acute myocardial infarction. J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):1–6. [PubMed] [Google Scholar]

ACTIONS

RESOURCES